Blog Posts

“Lung Cancer Is Treatable, and Patients Deserve to Know That” – ACS NLCRT on Shifting the Narrative in Cancer Care

ACS NLCRT/LinkedIn

Jun 12, 2025, 12:02

“Lung Cancer Is Treatable, and Patients Deserve to Know That” – ACS NLCRT on Shifting the Narrative in Cancer Care

American Cancer Society National Lung Cancer Roundtable shared a post on LinkedIn:

“Lung cancer is treatable, and patients deserve to know that.

Despite major advances in treatment, stigma and outdated beliefs still shape how lung cancer is discussed. This Cancer Survivors Month, the ACS NLCRT is spotlighting our new commentary published in Annals of Internal Medicine that outlines 9 actionable recommendations to help shift the narrative.

Primary care clinicians are especially critical to this work, and many of the recommendations focus on how they can help replace nihilism with empathy and hope.

Read the commentary.”

ACS NLCRT

More posts featuring ACS NLCRT on OncoDaily.

ACS NLCRT American Cancer Society National Lung Cancer Roundtable Annals of Internal Medicine cancer Cancer Survivors Month Lung cancer OncoDaily Oncology Primary care clinicians

Patrick Soon-Shiong: 30 Years and $3B Toward a Universal Cancer Fighter

Dana Dornsife: After 19 Years, Lazarex Cancer Foundation Is Shuttering Because of Lack of Funding

Matt Sherer: ASCO Supports Permanent Medicare Telehealth

New FDA PreCheck Program to Boost U.S. Drug Manufacturing

Vinay Prasad Rejoins FDA Days After Exit